Dr. David E. Kandzari and Dr. C. Michael Gibson Discuss: OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG November 4, 2021 Disclosures: TBA
Dr. Andrew Holden and Dr. C. Michel Gibson: ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions October 18, 2020 Disclosures: TBA
Dr. Catalin Toma and Dr. C. Michael Gibson Discuss: FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population October 18, 2020 Disclosures: TBA
Dr. Ehrin Armstrong and Dr. C. Michael Gibson Discuss: TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes October 18, 2020 Disclosures: TBA
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020 Disclosures: TBD
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES October 17, 2020 Disclosures: TBA
Dr. Ajay Kirtane, Dr. Roxana Mehran, Dr. Mamas Mamas and Dr. C. Michael Gibson Discuss: TCT 2020 Daily Wrap-Up – October 17, 2020 October 17, 2020
Dr. Damien Collison and Dr. C. Michael Gibson Discuss: TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization October 16, 2020 Disclosures: TBD
Dr. Ajay Kirtane, Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: TCT 2020 Daily Wrap-Up – October 16, 2020 October 16, 2020
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Disrupt CAD III: Safety and Effectiveness of Intravascular Lithotripsy for Treatment of Severe Coronary Calcification October 16, 2020 Disclosures: TBD
